ImmuCell Corporation (ICCC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ImmuCell Corporation, updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$10.62
+3.51% today
Market cap
$93M
Overall quality
—
Kronos AI 30-day
−4.3%
1 of 8 simulated paths end higher
ImmuCell Corporation (ICCC) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $93M. It trades at $10.62, up 3.51% today. Kronos AI's 30-day forecast is −4.3% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $9.81 (−4.3%) |
| Likely range | −7.5% … −0.4% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.